Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$0.13 - $76.84 $3,380 - $2 Million
-26,000 Reduced 22.55%
89,300 $6.35 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $3,380 - $2 Million
-26,000 Reduced 22.55%
89,300 $6.35 Million
Q2 2022

Sep 21, 2023

BUY
$72.62 - $79.98 $6.19 Million - $6.82 Million
85,300 Added 284.33%
115,300 $8.88 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $6.19 Million - $6.82 Million
85,300 Added 284.33%
115,300 $8.88 Million
Q1 2022

Sep 21, 2023

SELL
$61.48 - $73.72 $7.38 Million - $8.85 Million
-120,000 Reduced 80.0%
30,000 $2.19 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $7.38 Million - $8.85 Million
-120,000 Reduced 80.0%
30,000 $2.19 Million
Q4 2021

Sep 21, 2023

BUY
$53.63 - $62.52 $5.9 Million - $6.88 Million
110,000 Added 275.0%
150,000 $9.35 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $5.9 Million - $6.88 Million
110,000 Added 275.0%
150,000 $9.35 Million
Q2 2021

Sep 21, 2023

SELL
$61.91 - $67.42 $3.05 Million - $3.32 Million
-49,300 Reduced 55.21%
40,000 $2.67 Million
Q2 2021

Aug 20, 2021

SELL
$61.91 - $67.42 $245 Million - $267 Million
-3,960,000 Reduced 99.0%
40,000 $2.67 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $247 Million - $269 Million
3,993,400 Added 60506.06%
4,000,000 $2.67 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $1.32 Million - $1.54 Million
-24,100 Reduced 78.5%
6,600 $388,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $8.13 Million - $11.8 Million
-175,200 Reduced 85.09%
30,700 $1.71 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $8.38 Million - $10.9 Million
-170,300 Reduced 45.27%
205,900 $13.2 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $12.4 Million - $14.7 Million
-289,500 Reduced 43.49%
376,200 $19.1 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $122 Million - $135 Million
-2,728,900 Reduced 80.39%
665,700 $30.2 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $149 Million - $178 Million
3,308,800 Added 3856.41%
3,394,600 $162 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $214,544 - $278,212
4,400 Added 5.41%
85,800 $4.46 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $22,076 - $24,900
400 Added 0.49%
81,400 $5.05 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $29.7 Million - $37 Million
-586,800 Reduced 87.87%
81,000 $4.48 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $14.3 Million - $16.4 Million
238,000 Added 55.37%
667,800 $42.2 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $35,964 - $39,210
-600 Reduced 0.14%
429,800 $26.3 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $23.8 Million - $27.4 Million
430,400
430,400 $27.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.